α1-Adrenoceptor Subtype Selectivity and Organ Specificity of Silodosin (KMD-3213) |
| S. Tatemichi, K. Kobayashi, A. Maezawa, M. Kobayashi, Y. Yamazaki, and N. Shibata |
| J. Pharm. Soc. Jpn., 126, 209-216, 2006 |
|
Effects of Silodosin (KMD-3213) on Phenylephrine-induced Increase in Intraurethral Pressure and Blood Pressure in Rats-Study of the Selectivity for Lower Urinary Tract- |
| S. Tatemichi, K. Kobayashi, I. Maruyama, M. Kobayashi, Y. Yamazaki, and N. Shibata |
| J. Pharm. Soc. Jpn., 126, 217-223, 2006 |
|
Effect of Silodosin on Intraurethral Pressure Increase Induced by Hypogastric Nerve Stimulation in Dogs with Benign Prostatic Hyperplasia |
| Y. Tomiyama, S. Tatemichi, M. Tadachi, S. Kobayashi, M. Hayashi, M. Kobayashi, Y. Yamazaki, and N. Shibata |
| J. Pharm. Soc. Jpn., 126, 225-230, 2006 |
|
Duration of Action of Silodosin (KMD-3213) against Phenylephrine-induced Increase in Intraurethral Pressure in Rats |
| M. Kobayashi, S. Tatemichi, K. Kobayashi, T. Imamura, I. Maruyama, Y. Yamazaki, and N. Shibata |
| J. Pharm. Soc. Jpn., 126, 231-236, 2006 |
|
Pharmacokinetics and Disposition of Silodosin (KMD-3213) |
| Y. Matsubara, T. Kanazawa, Y. Kojima, Y. Abe, K. Kobayashi, H. Kanbe, H. Harada, Y. Momose, S. Terakado, Y. Adachi, and Ian Midgley |
| J. Pharm. Soc. Jpn., 126, 237-245, 2006 |
|
Toxicity Profile of Silodosin (KMD-3213) |
| S. Muto, H. Kasahara, R. Yokoi, M. Hayashi, S. Souma, K. Kobayashi, T. Tamura, M. Murakami, J. Kuroda, and N. Shibata |
| J. Pharm. Soc. Jpn., 126, 247-256, 2006 |
|